UCL Cancer Institute


Welcome to the UCL Cancer Institute 

The UCL Cancer Institute is the hub for cancer research at University College London, one of the World's leading universities. The Institute draws together over 300 talented scientists who are working together to translate research discoveries into developing better, more effective treatments to improve outcomes for cancer patients. If you are considering postgraduate study with us, applications to our flagship MSc Cancer programme are open until 29th July 2016 for September entry. 


Improvements in epigenomic sequencing technologies could enhance cancer diagnostics

An international research collaboration led by UCL scientists has developed ways to improve the quality and accuracy of information harvested from epigenome sequencing datasets in two new research papers published jointly in Nature Biotechnology and Nature Communications today. According to the studies, epigenome sequencing technologies can allow for more comprehensive analysis of cancers - a key component in the development of targeted approaches to combat cancer.

Published: Jun 27, 2016 5:09:23 PM

Launch of new clinical research facilities to advance cancer diagnostics and therapies at UCL/UCLH

The final stages of an £8.9 million award to advance cancer medical research facilities at UCL/UCLH, were celebrated last night with a launch event marking the implementation of new cancer genomics and imaging technologies that will support two world-class cancer research programmes. The event, hosted at the UCL Cancer Institute, featured keynote speeches from Dr Jim Smith, MRC Deputy Chief Executive and Chief of Strategy and Professors Mark Emberton, Tim Meyer and Tariq Enver, who will be leading the research projects at UCLH and UCL.

Published: Jun 16, 2016 3:16:06 PM

Cancer drugs could target autoimmune diseases

Drugs currently being trialled in cancer patients have been used to successfully target an autoimmune condition in mice at UCL and King’s College London, according to a new study published in Cell Reports. Researchers are investigating the potential of using the treatment in a number of other auto-inflammatory conditions.

Published: Jun 13, 2016 3:13:44 PM

Dr Martin Pule named BBSRC Most Promising Innovator 2016

Dr Martin Pule has been named BBSRC Most Promising Innovator 2016 for his frontier innovations in T-cell medicine. The competition is designed to recognise the full breadth of BBSRC-funded research and rewards individuals and small teams who have harnessed the potential of their excellent research.

Published: May 20, 2016 11:43:27 AM

Cancer Research UK-UCL Centre

Cancer Research UK-UCL Centre

The Cancer Research UK-UCL Centre is a network and partnership between Cancer Research UK, UCL and UCL's associated Hospital Trusts. The Centre's mission is to facilitate collaboration to advance world-class translational cancer research.

Study with us

Study with us

Our education programmes reflect the depth and breadth of research expertise within the UCL Cancer Institute. Join our community of research scientists and academic clinicians through our postgraduate taught MSc Cancer or PhD studies.

Clinical Trials

Clinical Trials

The Cancer Research UK and UCL Cancer Trials Centre is one of the largest cancer trials centres in the UK. The CTC conducts multi-centre national and international phase III trials, feasibility studies and early phase I and II studies.

Our Research

Our Research

UCL is a world leader in interdisciplinary research. The UCL Cancer Institute us uniquely placed to leverage this multidisciplinary approach to advance discoveries in basic, translational and clinical cancer research.


UCL Cancer Institute Multidisciplinary Seminar Series

Professor Heather Payne, Consultant in Clinical Oncology, UCLH and Professor Gary Royle, UCL Dept. of Medical Physics and Biomedical Engineering, present this seminar on research and developments in radiotherapy. Thursday 30th June, 12pm. 

Starts: Jun 30, 2016 12:00:00 PM

Biobank and Pathology Introductory Seminar

Join Dr Joanne McDonald and Dr Gareth Gerrard as they host an introductory seminar on the Biobank and Pathology Core Facilities available at UCL/UCLH, Friday 1st July 10.00 - 11.00am.

Starts: Jul 1, 2016 10:00:00 AM

Web chat with Dr Beth Payne, Consultant Haematologist

Join clinical researcher and consultant Dr Beth Payne in web chat session: Managing myelodysplastic syndromes (MDS)  from diagnosis to treatment, Wednesday 6 July 12.00- 1.00pm.

Starts: Jul 6, 2016 12:00:00 PM

Support our work

The progress we make in understanding and developing treatments for cancer is made possible by the generous support of individuals, companies and charitable trusts and foundations. Our donors support us every step of the way in the ongoing fight against cancer. 

Find out more about how you can help us to continue research that will lead to breakthroughs in cancer therapies and benefit the lives of cancer patients.


Taking action for equality

Athena Swan silver logo

Connect with us